---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-128428"
form_type: "8-K"
ticker: "HYPD"
cik: "0001682639"
company_name: "HYPERION DEFI, INC."
filed_at: "2024-12-13T23:59:59+00:00"
generated_at: "2026-05-29T03:38:53.039850+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.95
calibrated_materiality_score: 0.95
confidence: "high"
source: SEC EDGAR
---

# Eyenovia receives Nasdaq delisting notice due to low stock price; plans to appeal

## Summary
- Nasdaq determined to delist Eyenovia's common stock because closing bid price was $0.10 or less for 10 consecutive trading days as of December 11, 2024.
- The Bid Price Cure Period (until March 17, 2025) was rendered unavailable by the Low Priced Stocks Rule.
- Eyenovia intends to appeal the delisting determination by December 19, 2024; appeal will stay suspension pending a Hearings Panel decision.
- On December 12, 2024, filed preliminary proxy for a special meeting on January 21, 2025 to approve a reverse stock split to regain compliance.
- No assurance of favorable decision from Nasdaq or that reverse split will increase stock price.

## SEC filing metadata
- accession: 0001104659-24-128428
- form_type: 8-K
- ticker: HYPD
- cik: 0001682639
- company_name: HYPERION DEFI, INC.
- filed_at: 2024-12-13T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.95
- calibrated_materiality_score: 0.95
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1682639/000110465924128428/0001104659-24-128428-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1682639/000110465924128428/tm2431083d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-128428
- JSON: https://secwatch.observer/filing/0001104659-24-128428.json
- Plain text: https://secwatch.observer/filing/0001104659-24-128428.txt

## Key facts
- Listing & Compliance Notices
  HYPERION DEFI, INC. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)(iii)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)(iii)
  source text: December 12, 2024, the Company received a letter from Nasdaq notifying the Company that, as of December 11, 2024, the common stock had a closing bid price of $0.10 or less for 10 consecutive trading days. Accordingly, the Company is subject to the provisions of Listing Rule 5810(c)(3)(A)(iii) (the “Low Priced Stocks Rule”). As a result, Nasdaq has determined to delist the Company’s securities from The Nasdaq Capital Market, notwithstanding the Bid Price Cure Period, which is rendered unavailable by the Low Priced Stocks Rule. The Company has the right to appeal Nasdaq’s determination by Decemb
  evidence_url: https://www.sec.gov/Archives/edgar/data/1682639/000110465924128428/0001104659-24-128428-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.